BSE filing, BSE: 544611. Summary written from the filing by ALFA Finder's alert engine.
Mahamaya Lifesciences Ltd: key numbers
- Share price
- ₹176.00
- Market cap
- ₹411.9 Cr
- Revenue (annual)
- ₹329.3 Cr
- Net profit (annual)
- ₹16.72 Cr
- P/E (TTM)
- 24.6×Sector 34.1×
- Promoter holding
- 56.39%
- FII holding
- 2.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mahamaya Lifesciences Ltd
All →Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Mahamaya Lifesciences Business Update
Mahamaya Lifesciences announced the publication of an executive interview in AgroPages Magazine (2026 India Focus Issue), highlighting operational progress and strategic growth initiatives.
Mahamaya Lifesciences Management Change
Mahamaya Lifesciences Limited announced management changes including the appointment of Dr. Bhagirath Choudhary and re-appointment of two Independent Directors. The MD and Executive Director were also re-designated.
Mahamaya Lifesciences Annual General Meeting
Mahamaya Lifesciences Limited held its 24th Annual General Meeting on September 29, 2026. Shareholders considered resolutions including financial statement adoption, director re-appointments, and management re-designations.
Mahamaya Lifesciences Promoter Buying
Promoter Prashant Krishnamurthy acquired 7,200 equity shares of Mahamaya Lifesciences Ltd through open market purchases on BSE.
- Promoter stake change
- +0.02%
Other board meeting date announcements
All →Compucom Software Board Meeting Date
Compucom Software has scheduled a board meeting on November 13, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The filing also restates the trading window closure for designated persons.
Sika Interplant Systems Board Meeting Date
Sika Interplant schedules a board meeting on 14 November 2026 to approve quarterly unaudited results. Trading window stays closed until 48 hours after the meeting.
Maruti Global Industries Board Meeting Date
Maruti Global Industries will hold a board meeting on 13 November 2026 to consider unaudited results for the quarter and half-year ended 30 September 2026. The trading window stays closed until 15 November 2026.
Rose Merc Board Meeting Date
Rose Merc Ltd intimated BSE of a board meeting on November 12, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closure is also noted.
Orient Cables (India) Board Meeting Date
Orient Cables schedules a board meeting on 12 November 2026 for unaudited Q2 and half-year results. Trading window stays closed until 48 hours after results declaration.
Share Samadhan Board Meeting Date
Share Samadhan schedules a board meeting on 12 November 2026 for unaudited half-year results. Trading window stays closed until 48 hours after results declaration.